TrialInternational journal of hematology2005

Low-dose granulocyte colony-stimulating factor overcomes neutropenia in the treatment of non-Hodgkin's lymphoma with higher cost-effectiveness.

Takeshi Hara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.